过敏性紫癜合并肺炎支原体感染患儿的特征表现及治疗结局分析

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore and analyze the clinical characteristics and treatment outcome of children with Henoch-Schönlein purpura （HSP）complicated with Mycoplasma pneumoniae infection，and to analyze the correlation between the recurrence of HSP and Mycoplasma pneumoniae infection.Methods Altogether 180 cases of patients with HSP and who received treatment in Puning People′s Hospital from March 2016 to November 2017 were selected as research objects according to the double blind method，and were divided into 95 cases of Mycoplasma infection group and 85 cases of non Mycoplasma infection group according to DNA test results of patients with Mycoplasma pneumoniae.Then，the clinical characteristics were analyzed and patients were given the treatment，and the each indexes changes of biochemical test and blood routine test after the treatment of two groups of patients were compared，and the hospitalization time and recurrence of the two groups were observed.Results The levels of total cholesterol （TC），aspartate aminotransferase （AST）and alanine aminotransferase （ALT）in Mycoplasma infection group were higher than those in non Mycoplasma infection group （P＜0.05）.The levels of white blood cell count （WBC），red blood cell count（RBC），platelet count（PLT）and hemoglobin （Hb）in Mycoplasma infection group were higher than those in the non Mycoplasma infection group （P＜0.05）.The hospitalization time in the Mycoplasma infection group was longer than that in the non Mycoplasma infection group，and the recurrence rate was higher than that in the non-Mycoplasma infection group，the differences were statistically significant（P＜0.05）.Conclusion The recurrence of patients with HSP is influenced by the infection factors of Mycoplasma pneumonia，which it is necessary to detect Mycoplasma pneumoniae DNA in patients with HSP as early as possible，and timely diagnose and treat，so as to reduce the recurrence rate of patients with HSP.

Key words： Henoch-Schö nlein purpura Mymcoplasma pneumoniae infection Clinical characteristics Methylprednisolone Cimetidine loratadine Montelukast sodium Azithromycin

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2019/V26/I4/146

［1］	戴本启，张志梅，王华好.儿童过敏性紫癜复发的危险因素分析［J］.海南医学，2018，29（9）：1239-1241.
［2］	夏小军，段赟.中医药治疗过敏性紫癜的思路与方法［J］.西部中医药，2016，29（5）：40-42.
［3］	Ozen S，Pistorio A，Iusan SM，et al.EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura，childhood polyarteritis nodosa，childhood Wegener granulomatosis and childhood Takayasu arteritis：Ankara 2008.Part II：final classification criteria［J］.Ann Rheum Dis，2010，69（5）：798-806.
［4］	高姗，张惠君，刘毅，等.过敏性紫癜患儿血清常见呼吸道感染病原体特异性IgM的检测结果分析［J］.山东医药，2017，57（11）：88-90.
［5］	林丽丹.儿童过敏性紫癜复发相关临床因素分析［J］.广州医科大学学报，2016，44（5）：68-70.
［6］	杜川，董璇，陈铖，等.儿童紫癜性肾炎244例的流行病学特征与肾脏受累危险因素分析［J］.西部医学，2017，29（9）：1268-1271.
［7］	王忠涛，王燕，马允东.阿奇霉素序贯联合多药治疗小儿肺炎支原体感染致过敏性紫癜的临床研究［J］.临床肺科杂志，2017，22（12）：2208-2211.
［8］	刘玲，刘福娟，尹美娜，等.过敏性紫癜患儿血小板参数及淋巴细胞功能变化［J］.河北医药，2017，39（8）：1189-1191.
［9］	张远达，董青伟，李荣敏，等.过敏性紫癜患儿 25-羟基维生素 D3 水平变化及意义［J］.中国当代儿科杂志，2017，19（3）：292-295.
［10］	黎文应，曾海深，张铭.咽拭子肺炎支原体DNA与血清肺炎支原体抗体检测在诊断小儿肺炎支原体肺炎中的比较［J］.实用医技杂志，2017，24（8）：864-865.
［11］	朱炎，丁守梅，杨丽，等.过敏性紫癜患儿感染病原菌分布与对T细胞亚群影响研究［J］.中华医院感染学杂志，2016，26（8）：1880-1881.
［12］	宋欣.孟鲁司特钠治疗小儿过敏性紫癜的临床疗效及其安全性［J］.临床医学研究与实践，2016，1（22）：55-57.
［13］	蔡惠东，潘剑蓉.阿奇霉素联合孟鲁司特钠治疗小儿肺炎支原体肺炎的疗效评价［J］.检验医学与临床，2017，14（17）：2590-2592.
［14］	葛神永，李志奇.阿奇霉素联合基础治疗对肺炎支原体感染引发过敏性紫癜患儿的临床效果观察［J］.实用临床医药杂志，2017，21（19）：231-232.
［15］	王岩.孟鲁司特钠联合双歧杆菌四联活菌治疗小儿过敏性紫癜的临床疗效［J］.安徽医药，2017，21（8）：1508-1511.